Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group

Published:2021-10 Issue:12 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Elgarten Caitlin W.¹²^ORCID,Wood Andrew C.³,Li Yimei⁴,Alonzo Todd A.⁵,Brodersen Lisa Eidenschink⁶,Gerbing Robert B.⁷,Getz Kelly D.²⁴^ORCID,Huang Y‐S Vera⁸,Loken Michael⁶,Meshinchi Soheil⁹,Pollard Jessica A.¹⁰¹¹,Sung Lillian¹²,Woods William G.¹³,Kolb E. Anders¹⁴,Gamis Alan S.¹⁵,Aplenc Richard¹²⁴

Affiliation:

1. Division of Oncology Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

2. Center for Pediatric Clinical Effectiveness Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

3. University of Auckland Auckland New Zealand

4. Department of Biostatistics, Epidemiology, and Informatics, Department of Pediatrics University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

5. University of Southern California Los Angeles California USA

6. Hematologics, Inc. Seattle Washington USA

7. Children's Oncology Group Monrovia California USA

8. Department of Biomedical Health Informatics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

9. Fred Hutchinson Cancer Research Center Seattle Washington USA

10. Dana‐Farber Cancer Institute Boston Massachusetts USA

11. Boston Children's Hospital Boston Massachusetts USA

12. The Hospital for Sick Children Toronto Ontario Canada

13. Aflac Cancer and Blood Disorders Center Emory University/Children's Healthcare of Atlanta Atlanta Georgia USA

14. Alfred I. duPont Hospital for Children Wilmington Delaware USA

15. Children's Mercy Hospital and Clinics Kansas City Missouri USA

Funder